Does DexCom (DXCM) Have a Long Runway For Growth?
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Dexcom Inc (DXCM)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
DexCom, Inc. (NASDAQ:DXCM) Q2 2024 Earnings Call Transcript
Operator: Welcome to the Dexcom Second Quarter 2024 Earnings Release Conference Call. My name is Abby and I'll be your operator for today's call.
Is DexCom (DXCM) Trading at a Discount Now?
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Growth Stocks To Buy Now According To Billionaire Ray Dalio
Ray Dalio is one of the most successful investors in Wall Street's history.
DexCom, Inc. (NASDAQ:DXCM) Q1 2024 Earnings Call Transcript
DexCom, Inc. beats earnings expectations. Reported EPS is $0.32, expectations were $0.27. DexCom, Inc.
14 Best 52-Week High Stocks To Invest In Now
This article delves into the examination of the 14 best 52-week high stocks to buy now.
5 Best Weight Loss Drug Stocks to Buy Now
In this piece, we will take a look at the five best weight loss drug stocks to buy now.
Should You Hold DexCom (DXCM)?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.
Insiders Are Dumping These 5 Healthcare Stocks
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) is a clinical stage biopharma company that is working on treatments for endocrine-related diseases.
Here's What Happened to Dexcom (DXCM) Stock in Q4
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2023 investor letter.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
